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 • ,,Health care systems in Europe are largely 
based on the principles of health as a human 
right, on equitable access to health and health 
services, quality of health care, on solidarity, 
and on the active participation of society as a 
whole. Because of the difficulties associated 
with rising costs,  it is today vital to translate 
those ideals into achievements which are 
quantifiable both in terms of health and of 
expenditure; only with the help of such exact 
information can one hope to develop 
defensible policies which balance initiatives 
against resources.(Drugs and money-WHO)”  
•   
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• Rapid development in health technologies      
     affects health policies of countries. Thus     
     Governments try to provide high quality,     
      equal and accessible health care to public  
      while managing health care budgets.  
 
• Countries also contributed to the 
regional/global development of HTA by 
establishing networks according to their 
mutual interest. 
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•HTA helps evidence-informed policy decisions 
where we aim to gain more value with limited 
resources. 
•  Clinical practice guidelines are the 
knowledge tools that help clinicians and 
patients make evidence-based health care 
decisions.  
•Both needs to be developed in order to 
ensure an evidence informed decision making 
ecosystem.  
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• short presentation of the outcomes and 
objectives of the joint activities of the 
countries belonging to the Euroasian Initiative 
 
• background of the Initiative 
 
• sharing experience between the panelists and 
audience 
 
• coming to some common impressions and 
conclusions 
THE STRUCTURE OF THE PANEL DISCUSSION 
 • This panel will create a platform where experiences in 
Eurasian countries can be shared with the HTA society, 
especially important that some countries will have their 
first opportunity to attend HTAi annual meeting.  
• The panel will also allow audience to actively participate 
in the discussions which will increase interaction 
between different settings. 
OUTCOMES AND OBJECTIVES 
 
Development of HTA in the last few decades 
has not been limited to Europe and North 
America. Latin American and Asian 
countries have invested in HTA and these 
countries also contributed to the 
regional/global development of HTA by 
establishing networks according to their 
cultural and geographical proximity, or the 
commonality of systems.  
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 Considering the actual global situation 
regarding permanent growth of health care 
expenditures especially in developing countries,  
Eurasian HTA Forum note the importance of HTA 
as a multidisciplinary activity that systematically 
examines the safety, clinical efficacy and 
effectiveness, cost-effectiveness, organizational 
implications, social consequences as well as  
legal and ethical considerations of the 
application of a health technology, no matter if it 
is related to  a drug, medical device,  clinical or 
surgical procedure. 
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introduction 
• ,,Health care systems in Europe are largely based on the principles of health 
as a human right, on equitable access to health and health services, quality 
of health care, on solidarity, and on the active participation of society as a 
whole. Because of the difficulties associated with rising costs,  it is today 
vital to translate those ideals into achievements which are quantifiable 
both in terms of health and of expenditure; only with the help of such exact 
information can one hope to develop defensible policies which balance 
initiatives against resources.(Drugs and money-WHO)”  
•   
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Similarly, in 2015, Eurasian HTA Initiative was 
established with the leadership of Turkish 
Society of Evidence Based Medicine and 
included the countries ranging from Balkans 
to Central Asia that are thought to be new, 
but promising for developme t f HTA. There 
are 9 membercountries 
• Rapid development in health technologies affects health policies of countries. 
Thus Goverments try to provide high quality, equal and accessible health care 
to public while managing health care budgets.  
• Countries also contributed to the regional/global development of HTA by 
establishing networks according to their cultural and geographical proximity, 
or the commonality of systems.  
introduction • Interventions to improve use of HTA and 
guidelines in the region became a 
priority during members’ discussions.   
 
• Both needs to be developed in order to 
ensure an evidence informed decision-
making ecosystem.  
 
• To what extent are these needs, was 
identified by deep analysis of the 
situation.  
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introduction 
•HTA helps evidence-informed policy decisions where we aim to gain 
more value with limited resources. 
 
•  Clinical practice guidelines are the knowledge tools that help 
clinicians and patients make evidence-based health care decisions. 
Both needs to be developed in order to ensure an evidence 
informed decision making ecosystem.  
• To improve HTA in the member countries.  
 
• The members conducted SWOT (strengths, weaknesses, 
opportunities, and threats) analysis in enhancement of 
evidence-informed decision making for the members, 
where infrastructure, legal framework and lack of 
capacity were found to be three of the major common 
weaknesses for evidence based decision-making.  
THE AIM OF THE INITIATIVE 
The structure of the panel 
discussion 
• short presentation of the outcomes and objectives 
• background of the Initiative 
• sharing experience between the panelists and audience 
• coming to some common impressions and conclusions 
• National/Regional interest in multinational collaboration of 
advancing EBM practices 
• Genuine interest to capacity building in EBM practices 
• Availability of web-based resources 
• World Health Assembly resolution on promoting HTA in the 
countries 
• Existence of public health system (varying degree),  
• Introduction of clinical practice guidelines (to at least some 
degree) into the healthcare system,  
• Existing cross-border cooperation between most of the 
ember-countries f Eurasian network.  
• Interest of Governments to provide targeted funding of the 
cheapest possible services/technologies with highest 
impact and durable results. Interventions to improve use of 
HTA and guidelines in the region became a priority in 
members’ discussions.   
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Outcomes and objectives 
• This panel will create a platform where experiences in Eurasian 
countries can be shared with the HTA society, especially 
important that some countries will have their first opportunity 
to attend HTAi annual meeting.  
• The panel will also allow audience to actively participate in the 
discussions which will increase interaction between different 
settings. 
•  
 
• Low number of educated health personnel with 
adequate knowledge on critical appraisal and 
EBM 
• Lack of adequate number of certified/licensed 
EBM/HTA courses across the countries 
• Absence/scarcity of EBM-related courses 
• Lack of regional expertise in the field 
• Language barr er- the need for translations to 
local languages of common regional 
documents and vice versa. 
• Lack of legal framework for advancing EBM 
• Lack of enough willingness and use of HTA in 
decision making by relevant stakeholders 
• Lack of patients’ awareness of EBM practices 
and reluctance to take self-responsibility to 
participate in their treatment decisions 
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background 
 
•Development of HTA in the last few decades has not been 
limited to Europe and North America. Latin American and 
Asian countries have invested in HTA and these countries also 
contributed to the regional/global development of HTA by 
establishing networks according to their cultural and 
geographical proximity, or the commonality of systems.  
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• Interest in capacity building 
• Possibility of  joint activities in terms of improving EBM 
practices, with particular emphasis on HTAs 
• Growing interest on EBM among health professionals 
• Growing health expenditures, with a need to optimize use of 
available resources  
• Potential for relevant information 
• Possibility to organize webinars, open to all countries to 
selected EBM topics 
• Global support from countries with well-established EBM 
systems  
• Existence of EBM a sociations i  some c tri  in the 
region, as a triggering factor for the others 
• All partners are members of World Health Organization-Euro  
• WHO supporting HTA to be involved in universal health 
cover ge 
• Increasing demand of evidence on health technologies by 
patient organizations 
• Considering the actual global situation regarding permanent 
growth of health care expenditures especially in developing 
countries,  Eurasian HTA Forum note the importance of HTA as a 
multidisciplinary activity that systematically examines the safety, 
clinical efficacy and effectiveness, cost-effectiveness, organizational 
implications, social consequences as well as  legal and ethical 
considerations of the application of a health technology, no matter 
if it is related to  a drug, medical device,  clinical or surgical 
procedure. 
 
• Limited funding to be used for EBM development in the 
Region 
• Low level of understanding of EBM among policy/decision 
makers, academia and general public 
• Industry influence on medical decision making 
• Mismatch between demands and available resources to 
fulfill EBM requirements 
• No incentives for EBM practices, beyond physicians’ self-
consciousness 
• Hard-core cultural beliefs of some senior physicians for a 
cultural change favoring EBM practices 
• Discontinuation of people and efforts, tendency to give up 
• Political influence to the health policies 
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• Similarly, in 2015, Eurasian HTA Initiative was established with the 
leadership of Turkish Society of Evidence Based Medicine and 
included the countries ranging from Balkans to Central Asia that are 
thought to be new, but promising for development of HTA. The 
members are Albania, Azerbaijan, Bosnia and Herzegovina, 
Macedonia, Montenegro, Kazakhstan, Krygyzstan, Turkey and 
Tunisia. 
The resource-limited settings, such as 
members of this initiative, need to align 
these activities to make sure that the 
resources are used efficiently, 
decisions made are evidence-informed 
and the existing c pacity coll borates 
to have a communicative system. 
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• Similarly, in 2015, Eurasian HTA Initiative was established with the 
leadership of Turkish Society of Evidence Based Medicine and 
included the countries ranging from Balkans to Central Asia that are 
thought to be new, but promising for development of HTA. The 
members are Albania, Azerbaijan, Bosnia and Herzegovina, 
Macedonia, Montenegro, Kazakhstan, Krygyzstan, Turkey and 
Tunisia. 
They will provide information on activities 
in their respective countries and will lay 
out challenges they are facing. 
 
• Ahmed Novo (Federation of Bosnia and 
Herzegovina 
• Temirkhan Kulkh n (Kazakhstan)  
• Khaled Zghal  (Tunisia) 
• Rabia Kahveci (Turkey) 
 
P 
R 
E 
S 
E 
N 
T 
E 
R 
S 
• Similarly, in 2015, Eurasian HTA Initiative was established with the 
leadership of Turkish Society of Evidence Based Medicine and 
included the countries ranging from Balkans to Central Asia that are 
thought to be new, but promising for development of HTA. The 
members are Albania, Azerbaijan, Bosnia and Herzegovina, 
Macedonia, Montenegro, Kazakhstan, Krygyzstan, Turkey and 
Tunisia. 
P 
A 
N 
E 
L 
I 
S 
T 
S 
 
 
All other participants who have participated to 
design this panel session are mentioned bellow, 
and are invited to express their examples about 
experiences in their respective countries, and 
give some ideas for improvement 
 
• Sinisa Stevic (Republika Srpska), 
• Merjem Hadzih mza (M ce onia) 
• Sanja Simovic  (Montenegro),  
• Alma Bajram spahic (Montenegro) 
• Bermet Baryktabasova (Kyrgyzstan),  
• Mirela Cela (Albania),  
 
• Similarly, in 2015, Eurasian HTA Initiative was established with the 
leadership of Turkish Society of Evidence Based Medicine and 
included the countries ranging from Balkans to Central Asia that are 
thought to be new, but promising for development of HTA. The 
members are Albania, Azerbaijan, Bosnia and Herzegovina, 
Macedonia, Montenegro, Kazakhstan, Krygyzstan, Turkey and 
Tunisia. 
All other participants are more than w lcomed  
to join t e pan l discussion to extend the 
opportunities to learn from each others.   
AUDIENCE-YOU ARE WELCOME 
• Similarly, in 2015, Eurasian HTA Initiative was established with the 
leadership of Turkish Society of Evidence Based Medicine and 
included the countries ranging from Balkans to Central Asia that are 
thought to be new, but promising for development of HTA. The 
members are Albania, Azerbaijan, Bosnia and Herzegovina, 
Macedonia, Montenegro, Kazakhstan, Krygyzstan, Turkey and 
Tunisia. 
